Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS)

18 filings reported holding BRNS - Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share as of Q2 2024.
Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9.91M shares of 40.3M outstanding shares and own 24.61% of the company stock.
Largest 10 shareholders include M&G Plc (5.2M shares), Alphabet Inc. (1.51M shares), HSG Holding Ltd (1.42M shares), DC Funds, LP (642K shares), BlueCrest Capital Management Ltd (543K shares), Baird Financial Group, Inc. (268K shares), Johns Hopkins University (122K shares), UBS Group AG (86.7K shares), RENAISSANCE TECHNOLOGIES LLC (25.1K shares), and Ipswich Investment Management Co., Inc. (23.1K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.